eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 17 | 18 | +1 |
| Shares | 938.8K | 868.0K | −70.8K (−7.5%) |
| Value | $13.5M | $251.1K | −$13.2M (−98.1%) |
New holders (8)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 352,084 | $102.1K | 1.36% |
| UBS Group AG | 61,667 | $17.9K | 0.00% |
| HRT Financial LP | 21,528 | $6.00K | 0.00% |
| Jane Street Group, LLC | 18,669 | $5.42K | 0.00% |
| Virtu Financial LLC | 18,021 | $5.00K | 0.00% |
| Two Sigma Investments, LP | 11,115 | $3.22K | 0.00% |
| Barclays PLC | 100 | $29 | 0.00% |
| Bank of America Corp | 31 | $9 | 0.00% |
Sold out (7)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Armistice Capital, LLC | 223,000 | $3.21M |
| StemPoint Capital LP | 132,793 | $1.91M |
| Sectoral Asset Management Inc | 95,305 | $1.37M |
| Ensign Peak Advisors, Inc | 32,945 | $474.1K |
| Raymond James & Associates | 12,345 | $177.6K |
| ICA Group Wealth Management, LLC | 247 | $3.56K |
| Wells Fargo & Company | 19 | $273 |